OSR HEALTH, INC. Increase Decrease In Operating Lease Liability
OSR HEALTH, INC. (OSRH) reported Increase Decrease In Operating Lease Liability of -$18.20 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- OSR HEALTH, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$7.62K.
- OSR HEALTH, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$10.58K.
- OSR HEALTH, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$14.50K.
- OSR HEALTH, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$13.03K.
- OSR HEALTH, INC. increase decrease in operating lease liability for fiscal 2025 was -$54.84K.
- OSR HEALTH, INC. increase decrease in operating lease liability for fiscal 2024 was -$73.68K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$7.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$18.20K 10-Q · filed 2026-08-14 | -$32.69K derived: sum of 3 quarters · filed 2026-08-14 | -$45.73K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$10.58K 10-Q · filed 2026-05-13 | -$25.08K derived: sum of 2 quarters · filed 2026-05-13 | -$38.11K derived: sum of 3 quarters · filed 2026-05-13 | -$52.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$14.50K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$27.53K derived: sum of 2 quarters · filed 2026-03-31 | -$41.42K derived: sum of 3 quarters · filed 2026-08-14 | -$54.84K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$13.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$26.92K derived: sum of 2 quarters · filed 2026-08-14 | -$40.35K 10-Q · filed 2025-11-12 | -$54.47K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$13.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$27.31K 10-Q · filed 2026-08-14 | -$41.44K derived: sum of 3 quarters · filed 2026-08-14 | -$68.61K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$13.42K 10-Q · filed 2026-05-13 | -$13.42K 10-Q · filed 2025-05-20 | -$27.55K derived: sum of 2 quarters · filed 2026-05-13 | -$54.72K derived: sum of 3 quarters · filed 2026-05-13 | -$70.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$14.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$41.30K derived: sum of 2 quarters · filed 2026-03-31 | -$57.23K derived: sum of 3 quarters · filed 2026-03-31 | -$73.68K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$27.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$43.11K derived: sum of 2 quarters · filed 2025-11-12 | -$59.55K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$15.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$32.38K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$16.45K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |